Co-Diagnostics Inc CODX:NASDAQ

Last Price$7.49NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.77(9.32%)
Bid (Size)$7.36 (5)
Ask (Size)$7.67 (3)
Day Low / High$7.36 - 8.22
Volume1.0 M

View Biotechnology IndustryPeer Comparison as of 01/21/2022


Co-Diagnostics Inc ( NASDAQ )

Price: $7.49
Change: -0.77 (9.32%)
Volume: 1.0 M
4:00PM ET 1/21/2022

Epizyme Inc ( NASDAQ )

Price: $2.07
Change: -0.12 (5.48%)
Volume: 954.0 K
4:00PM ET 1/21/2022

Magenta Therapeutics Inc ( NASDAQ )

Price: $3.57
Change: -0.15 (3.91%)
Volume: 249.4 K
4:00PM ET 1/21/2022

Fortress Biotech Inc ( NASDAQ )

Price: $2.05
Change: -0.05 (2.38%)
Volume: 615.7 K
4:00PM ET 1/21/2022

Esperion Therapeutics Inc ( NASDAQ )

Price: $3.78
Change: +0.01 (0.27%)
Volume: 1.5 M
4:00PM ET 1/21/2022

Read more news Recent News

Co-Diagnostics' Joint Venture Gets Approval for Human Papillomavirus High-Risk PCR Test in India
10:18AM ET 1/13/2022 MT Newswires

Co-Diagnostics (CODX) said Thursday that India's Central Drugs Standard Control Organization has cleared the company's CoSara Diagnostics joint venture to...

Co-Diagnostics Closes Purchase of Idaho Molecular, Advanced Conceptions
9:45AM ET 12/31/2021 MT Newswires

Co-Diagnostics (CODX) said Friday it completed its acquisition of Idaho Molecular and Advanced Conceptions for about 4.72 million Co-Diagnostics shares and...

--Sidoti Initiates Coverage on Co-Diagnostics With Buy Rating, $14 Price Target
8:55AM ET 12/29/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Climbing in Late Trade
3:41PM ET 12/22/2021 MT Newswires

Health care stocks were finishing just under their intra-day highs this afternoon, with the NYSE Health Care Index rising 1.0% while the SPDR Health Care...

Company Profile

Business DescriptionCo-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT. View company web site for more details
Address2401 South Foothill Drive
Salt Lake City, Utah 84109
Number of Employees20
Recent SEC Filing01/14/2022D
Chairman, President & Chief Executive OfficerDwight Howard Egan
Chief Financial Officer & SecretaryBrian L. Brown
Chief Scientific OfficerJesse Montgomery
General CounselReed L. Benson

Company Highlights

Price Open$8.09
Previous Close$8.26
52 Week Range$7.01 - 20.69
Market Capitalization$216.4 M
Shares Outstanding28.9 M
SectorHealth Technology
Next Earnings Announcement03/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings5.35
Earnings per Share$1.42
Beta vs. S&P 500N/A
Revenue$39.9 K
Net Profit Margin40.11%
Return on Equity50.81%

Analyst Ratings as of 12/28/2021

Consensus RecommendationConsensus Icon
Powered by Factset